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Abstract The role of partial AZFc deletions of the Y
chromosome in spermatogenic impairment is currently
debated. Recently, it was also reported that duplications of
the same region are associated with oligozoospermia in
Han-Chinese men. The aims of this study were (1) to evalu-
ate the clinical signiWcance of partial AZFc deletions in a
large study population and (2) to deWne if partial AZFc
duplications are a risk factor for spermatogenic failure also
in a Caucasian population such as the Italian. We screened
556 infertile patients and 487 normozoospermic controls
for partial AZFc deletions with a combined method based
on STS+/¡ followed by CDY1-DAZ gene dosage and copy
analysis. For the second aim, we performed CDY1-DAZ
gene dosage in 229 infertile patients and 263 normozoo-
spermic controls. The frequency of gr/gr deletions in
patients was signiWcantly diVerent from the controls (3.2
vs. 0.4%, respectively; P < 0.001), with an OR = 7.9 (95%
CI 1.8–33.8). b2/b3 deletions were rare in both groups
(0.5% in patients, 0.2% in controls). Concerning gr/gr
duplications, we observed no signiWcant diVerences in their
frequency between cases (2.6%) and controls (3.8%). This
is the largest study population in the literature in which all
potential methodological and selection biases were care-
fully avoided to detect the clinical signiWcance of partial
AZFc deletions and duplications. Our study provides strong
evidence that gr/gr deletion is a risk factor for impaired
spermatogenesis, whereas we did not detect a signiWcant
eVect of b2/b3 deletions and partial AZFc duplications on
spermatogenesis in this Caucasian ethnic group.
Introduction
The AZFc region of the Y chromosome consists almost
entirely of repetitive sequence blocks called “amplicons,”
which are arranged in direct and inverted repeats including
eight major palindromes (Skaletsky et al. 2003). Given its
repetitive nature, the AZFc region is particularly susceptible
to homologous intrachromosomal recombination events,
which may lead to deletions. DiVerent rearrangements at
AZFc have been identiWed, and some of them have been
reported to be either a direct cause or a risk factor for male
infertility. It is now widely accepted that complete dele-
tions of the AZFc region (b2/b4 deletion) is the most com-
mon known molecular genetic cause of spermatogenic
failure. This deletion type was never found in normosper-
mic men and thus shows a clear cut cause–eVect relation-
ship with spermatogenic impairment (Krausz and
Degl’Innocenti 2006). Recently, new types of AZFc dele-
tions, called “partial deletions,” have been reported
(Repping et al. 2003), which remove approximately half of the
AZFc gene content—including two DAZ, one CDY1 copies
and one BPY2 copy—and arise by the same molecular
mechanism of the complete AZF microdeletions. Among
them, gr/gr partial deletion is considered a genetic risk fac-
tor for spermatogenic impairment by a number of research
groups, including ours (see Table 1), while b2/b3 and b1/b3
Electronic supplementary material The online version of this 
article (doi:10.1007/s00439-008-0561-1) contains supplementary 
material, which is available to authorized users.
C. Giachini · I. Laface · E. Guarducci · G. Forti · C. Krausz (&)
Andrology Unit, Department of Clinical Physiopathology, 
University of Florence, Viale Pieraccini 6, 
50139 Firenze, Italy
e-mail: c.krausz@dfc.uniW.it
G. Balercia
Division of Endocrinology, Institute of Internal Medicine, 
Polytechnic University of Marche, 60100 Ancona, Italy123
400 Hum Genet (2008) 124:399–410deletions seem not to have signiWcant eVects on male fertil-
ity (Giachini et al. 2005; Hucklenbroich et al. 2005; Lynch
et al. 2005; Repping et al. 2004) with the exception of one
study in the Han-Chinese population (Wu et al. 2007).
The Wrst AZFc candidate gene isolated from the AZFc
interval was DAZ (deleted in Azoospermia), which is
expressed speciWcally in the testis (Reijo et al. 1995). The
DAZ gene family has been transposed from chromosome 3
(3p25, DAZL1 locus) on to the Y chromosome, where it is
present in four copies on the reference Y chromosome
sequence (DAZ1, DAZ2, DAZ3 and DAZ4). It would sug-
gest that DAZ genes are extending or improving the func-
tional proWle of their autosomal homologs, DAZL on
chromosome 3 and BOULE on chromosome 2 (Xu et al.
2001). The DAZ gene family encodes diVerent testis-spe-
ciWc RNA-binding proteins probably involved in the trans-
lational control of transcripts of other germ line genes (Yen
2004). Another AZFc testis-speciWc candidate gene is
CDY1, present in two copies (CDY1a and CDY1b) and
originated from a polyadenylated mRNA of the CDYL
locus on chromosome 6, which has been then retrotrans-
posed to the Y chromosome (Lahn and Page 1999). CDY
proteins were identiWed as histone acetyltransferases
with a strong preference for histone H4 and localized in the
nuclei of maturing spermatids (Lahn et al. 2002). Histone
hyperacetylation in late spermatids results in a more open
chromatin structure, which facilitates not only the sper-
matogenic histone replacement but also provides an easier
access of the transcriptional machinery to the postmeiotic
sperm DNA. Another AZFc gene involved in micro- and
partial deletion is BPY2, of which function is unknown, and
Wve transcription units, TTTY3, TTTY4, TTTY17, CSPG4LY
and GOLGA2LY.
In our previous study, using a combined method based
on gene dosage and gene copy deWnition of two AZFc
genes (DAZ and CDY1), we identiWed diVerent subtypes of
gr/gr deletions characterized by the loss of diVerent gene
copies (Giachini et al. 2005, 2007). A signiWcantly higher
frequency of CDY1a copy deletion and DAZ1/DAZ2 dele-
tion was found in the oligozoospermic group in respect to
the normozoospermic group suggesting that certain dele-
tion patterns may be more pathogenic than others (Giachini
et al. 2005). 
Homologous recombination between AZFc amplicons
can generate, other than partial AZFc deletions, also partial
AZFc duplications, which may occur among diVerent
amplicons. In a recent study on Taiwanese population, Yen
and her group focused their interest on two types of partial
AZFc duplications: (1) gr/gr duplication, which spans
1.6 Mb and involves nine genes, and (2) b2/b3 duplication,
Table 1 Summary of gr/gr deletion case–control studies available in the literature, with or without association with spermatogenic disturbances
Ethnic/geographic origin and the size of the study populations are reported. Since the inclusion criteria for controls were diVerent in diVerent stud-
ies (general population or proven fertile men with unknown sperm count or normozoospermic men), the percentage of normozoospermic men in
each control group is indicated
a Gene dosage was performed only in these studies (i.e., only in four of the 16 studies)
References Population Patients Controls
Total n gr/gr % Total n gr/gr % Normozoospermic %
Association Repping et al. (2003)a Dutch 246 3.7 148 0.0 100
de Llanos et al. (2005) Spanish 283 4.2 232 0.0 14.6
Ferlin et al. (2005) Italian 337 4.7 263 0.4 100
Giachini et al. (2005)a Italian 150 5.3 189 0.5 100
Lynch et al. (2005) Australian 1,351 4.1 234 0.4 57.3
Navarro-Costa et al. (2007) Portuguese 300 5.3 300 1.0 0
Yang et al. (2008) Han-Chinese 414 10.6 262 5.3 100
No association Machev et al. (2004)a French (admixed) 300 6.0 399 3.5 1
Hucklenbroich et al. (2005) German 348 4.0 170 1.8 100
Ravel et al. (2006) Admixed 192 2.1 181 3.3 8.8
de Carvalho et al. (2006a) Brazilian 110 4.5 240 2.5 0
de Carvalho et al. (2006b) Japan 78 28.2 56 33.9 0
Zhang et al. (2006)a East Asian 87 10.3 89 10.1 100
Fernando et al. (2006) Sri Lanka 96 4.2 89 4.6 100
Wu et al. (2007) Han-Chinese 439 7.0 248 7.7 34.6
Lardone et al. (2007) Chilean 95 2.1 77 2.6 40.2
Imken et al. (2007) Moroccan 145 4.7 176 4.0 43.2
StouVs et al. (2008) Mixed Caucasian 187 4.3 394 3.0 70.5123
Hum Genet (2008) 124:399–410 401which spans 1.8 Mb and involves 12 genes. The authors
found an association between AZFc partial duplications and
male infertility (Lin et al. 2007). The authors suggested that
some AZFc gene would be dosage-sensitive and their
increased expression may interfere with normal spermato-
genesis.
Given that the reliability of case–control association
studies are strongly dependent on the size of the study pop-
ulation, we aimed to verify if our previous Wnding on par-
tial AZFc deletions in a relatively small study population
(n = 339) can be replicated in a much larger study popula-
tion (n = 1043). Moreover, since the majority of the pub-
lished studies dealing with gr/gr deletions suVer from
selection and methodological biases, there is an urgent need
for large, unbiased studies able to provide reliable informa-
tion about the clinical signiWcance of gr/gr deletions. Our
second aim was to deWne whether partial AZFc duplication
is associated with an increased risk of spermatogenic fail-
ure also in a Caucasian population, such as the Italian, or it
is restricted to the Taiwanese Han-Chinese population.
Materials and methods
Subjects
Infertile patients included in the study were seeking com-
plete andrological work-up for couple infertility at the
Andrology Unit and the Unit of Physiopathology of Repro-
duction of the University Hospital Careggi (Florence) and
at the Endocrinology Unit of the University of Ancona.
Infertile patients were selected on the basis of a comprehen-
sive andrological examination including medical history,
semen analysis, scrotal ultrasound, hormone analysis,
karyotype and Y chromosome microdeletion screening.
Patients with mono or bilateral cryptorchidism, varicocele
of grades 2 and 3, obstructive azoospermia, recurrent infec-
tions, iatrogen infertility, hypogonadotrophic hypogonad-
ism, karyotype anomalies, Y chromosome microdeletions
and patients with no-Central Italian origin were excluded.
Concerning the study of partial AZFc duplications, we
selected only subjects with the absence of partial AZFc
deletions. Controls were selected on the basis of normal
sperm parameters (sperm count, motility and morphology)
deWned according to the WHO criteria (World Health Orga-
nization 1999). The origin of controls were the following:
(1) voluntaries (55%); (2) male partners of infertile couples
with ascertained female factor (30%); (3) men attending at
the andrology laboratory for semen analysis for secondary
infertility (previous fertility with the same or an other part-
ner) or for “andrological control” (15%). Forty percent of
normozoospermic controls were also proven fertile men,
since they fathered at least one child spontaneously or had
normal fertilization after in vitro fertilization for pure tubal
factor infertility.
To exclude recruitment bias, much care was taken for
the ethnic and geographic matching of the patients and con-
trols. All patients and controls were explicitly asked for
their paternal and maternal origin (i.e., if the family of their
mother and father were originally from Central Italy) and
selected only those with Central Italian ancestry. In addi-
tion, we performed Y haplogroup (hgr) analysis in a pro-
portion of patients (n = 115) and controls (n = 171), which
showed a similar Y haplogroup distribution (with the high-
est frequency of hgr P, 40 and 45.6%, respectively)
between oligo/azoospermic and normozoospermic men
(personal communication of M. Mitchell).
Partial AZFc deletions
The study population consisted of 556 infertile patients and
487 normozoospermic controls. In the infertile group, 284
patients were “idiopathic” (without known abnormal andro-
logical Wndings in their medical history and at the medical
examination, normal hormone levels and normal genetic
tests) and 272 presenting cofactors with potential mild neg-
ative eVect on spermatogenesis [unilateral varicocele with
grade < 2, previous (not recurrent) infections of the urogen-
ital tract]. Although we divided our infertile patients into
two groups on the basis of presence/absence of mild cofac-
tors, it is worth to note that in the large majority of previous
studies the exclusion criteria were much less strict, poten-
tially including among “cases” also infertile men with well
known causes of spermatogenic failure. Exclusion criteria
from previous studies are reported in Supplementary
Table 1.
According to the three major sperm parameters, the
infertile group can be divided as follows: azoospermia in
72 patients; cryptozoospermia (<1 million spermatozoa/
ml) in 26 patients; severe oligozoospermia (1–5 millions
spermatozoa/ml) in 187 patients; moderate oligozoosper-
mia (5–20 milions spermatozoa/ml) in 271 patients. One
hundred and twenty-one infertile men and 189 controls
were already analyzed in our previous study (Giachini
et al. 2005).
Partial AZFc duplications
The study population consisted of a total of 492 subjects:
(1) 229 infertile patients (120 “idiopathic” and 109 with
“cofactors”) and (2) 263 normozoospermic men. The
patient group included 37 azoospermic, 15 cryptozoosper-
mic, 80 severe oligozoospermic and 97 moderate oligozoo-
spermic men. Samples were collected using approved
protocols, and the informed consent of all individuals was
obtained according to the local ethical committee policy.123
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We detected gr/gr deletions and b2/b3 deletions by a poly-
merase chain reaction (PCR) ampliWcation of Y chromo-
some sequence-tagged sites (STSs), originally described by
Repping et al. (2003): sY1291, sY1191, sY1161, sY1206,
sY142 and sY1197 (see GenBank accession numbers in the
original article). We identiWed gr/gr deletions by the fol-
lowing STS results: sY1291 negative; sY1191, sY1161,
sY1206, sY1201, sY142 and sY1197 all positive. The
b2/b3 deletion was characterized by the absence of the STS
sY1191 and the presence of the rest of the STSs. Positive
(man with intact AZFc) and negative controls (woman)
were screened with the samples to prevent false results.
Suspected deletions were conWrmed with subsequent PCR
at less stringent conditions.
DAZ and CDY1 gene dosage
To quantify the copy number of DAZ and CDY1 genes, we
performed a quantitative analysis, according to a previously
reported method (Giachini et al. 2007; Machev et al. 2004).
This method was validated against FISH analysis in the
original paper by Machev et al. (2004). Samples with
known copy number (previously analyzed with the original
Machev method) were included in each batch of samples.
The DAZ dosage method consists in the simultaneous
ampliWcation of a fragment of intron 10 from AZFc DAZ
copies and from its homolog DAZL (localized outside the
AZFc interval), using a single primer pair (o1130/o1313).
This intron is present in one copy per DAZ or DAZL gene
(according to the AZFc reference structure the number of
DAZ copies is four, whereas there are two copies of DAZL
in a normal 46,XY man). Thus, DAZL act as an internal
standard with a known number of copies. The primers Xank
an insertion/deletion diVerence of 3 bp, which allowed the
PCR products (DAZ: 214 bp; DAZL: 217 bp) to be sepa-
rated by polyacrylamide gel electrophoresis. One of the
primers (o1130) was labeled at its 5 end with a Xuoro-
chrome (FAM).
The quantitative analysis for CDY1 copies was analo-
gous to DAZ dosage. In the reference sequence of the AZFc
region, there are two copies of both CDY1 and CDY2,
which share 98% nucleotide identity. We ampliWed CDY1
and CDY2 across 3 bp indel diVerence in the coding region,
to give fragments of 134 bp for CDY1 and 137 bp for CDY2
(primers: oMY953a/o1023). oMY953a was labeled at its 5
end with a Xuorochrome (FAM).
For both DAZ and CDY1 dosage, the PCR reactions were
performed in a maximum of 23 cycles (end point within the
exponential phase). The PCR products were mixed with
formamide, denatured at 95°C for 5 min and the diVerent
size loci separated on automatic sequencer (ABI PRISM 310
Genetic Analyzer PE). QuantiWcation was performed com-
paring the peak area corresponding to the DAZ locus and to
its homolog DAZL and CDY1 to CDY2. Figure 1 reports
examples of diVerent DAZ and CDY1 gene dosages. Some
samples presented a 40-bp insertion polymorphism in the
DAZL intron 10, resulting in an extra band at 260 bp, which
could be in heterozygosis or, more rarely, in homozygosis.
Gene copy type deWnition
Qualitative analysis for CDY1 and DAZ was performed
according to Machev et al. (2004). For DAZ, we chose the
sequence family variant (SFV) at STS sY587 in intron 10,
which discriminates DAZ1/2 from DAZ3/4. In addition we
analyzed one SVF for each DAZ copy according to (Fernan-
des et al. 2002): (1) three single nucleotide variants
(SNVs)—DAZ-SNV I (for DAZ4), DAZ-SNV II (for DAZ1),
DAZ-SNV III (for DAZ2); (2) the STS Y-DAZ3 (for DAZ3).
For CDY1, we used a C/A SFV situated 7750 bp
upstream of the CDY1 translation start codon (CDY7750),
which distinguishes CDY1a from CDY1b. SFVs were
scored by PCR followed by enzyme digestion (except for
the STS Y-DAZ3) using the following enzymes: DraI for
DAZ sY587; FspI DAZ-SNV I; MboI for DAZ-SNV II;
TaqI for DAZ-SNV III; PvuII for CDY1-7750. Digestion
products were then analyzed by electrophoresis at 100 V on
4% agarose gels containing ethidium bromide and visual-
ized under ultraviolet light.
Y haplogroup deWnition
Individuals with partial AZFc deletions were genotyped in
the laboratory of C. Tyler Smith (Sanger Institut, Cam-
bridge, UK) in the context of a multicenter study using the
multiplexed primers previously described (Noordam and
Repping 2006) adapted for SNaPshot single base extension
(Applied Biosystems). The markers RPS4Y711, M145, M96,
M89, M9 and M45 were typed on all samples, and M123,
M78, V6, M35 and M81 (hg E—derived for M96), M201,
M170, M52 and 12f2 (hg F—derived for M89), M106,
M61, M147, M214, M27, M76 and M70 (hg K—derived
for M9), or M17, M343, M369 and M18 (hg P—derived for
M45) on appropriate subsamples, but data were combined
into the major hgs E, F*(£K), K*(£P) and P to provide
numbers suitable for most statistical analyses.
Individuals with partial AZFc duplications (except C74,
CS26, CS68, CS76, which were also haplotyped by the
aforementioned method) were genotyped for six binary
markers deWning Wve haplogroups: E, J, K*(£N, P), N, and
P, and one paragroup Y*(£A, D, E, J, K). Y chromosome
haplotyping was performed as previously published for the
YAP, M9, SRY1532, 92R7, LLy22 g and 12f2 polymor-
phisms (Rosser et al. 2000). Polymorphisms were visualized123
Hum Genet (2008) 124:399–410 403by restriction enzyme digest for M9 (HinfI), SRY1532
(DraIII), 92R7 and LLy22 g (HindIII).
Statistical analysis
Statistical analysis was performed using the statistical pack-
age SPSS for Windows (version 12.0.1, Chicago, IL, USA).
We tested the signiWcance of the observed diVerence in the
incidence of partial AZFc deletions and DAZ duplication
between the two study groups using Fisher’s exact test. Our
null hypothesis was that incidence is the same in infertile
patients and normospermic men. Median values between
groups were compared using a nonparametric Mann–Whit-
ney U test or Student’s t test after normalization of the distri-
bution by a log transformation, as shown by a one-sample
Kolmogorov–Smirnov test; P = 0.023. A P value of 0.05
was considered statistically signiWcant for each test.
Results
Partial AZFc deletions
Frequency and type of partial AZFc deletions in patients 
and normozoospermic men
Based on the STS+/¡ analysis, it was possible to identify
diVerent types of AZFc partial deletions: gr/gr deletions
(20/1,043) and b2/b3 (4/1,043). We did not identify any
b1/b3 deletion in our study population. In all gr/gr and
b2/b3 deletion cases, we found half copy number of DAZ
and CDY1, except for one sample (A624) with gr/gr pattern,
in which CDY1 and DAZ gene dosage was normal (for
details see below).
The gr/gr deletions were found in both infertile (18/556;
3.2%)—including A624—and normozoospermic men (2/487;
Fig. 1 Examples of electrophoretograms showing diVerent gene dos-
ages for the DAZ/DAZL and CDY1/CDY2 genes. The x-axis shows
length of PCR products in base pairs as determined by use of internal
lane standard and the y-axis shows the Xuorescent intensity in arbitrary
units. a The peak area of DAZ is compared to that of DAZL (corre-
sponding to two copies). A DAZ/DAZL pattern of 2:1 indicates four
DAZ copies (“normal” DAZ gene dosage according to the reference se-
quence), 1:1 indicates two DAZ copies, 3:1 indicates six DAZ copies.
b The peak area of CDY1 is compared to that of CDY2 (corresponding
to two copies). A CDY1/CDY2 pattern of 1:1 indicates two CDY1 cop-
ies (“normal” CDY1 gene dosage according to the reference sequence),
0.5:1 indicates one CDY1 copy and 1.5:1 indicates three CDY1 copies
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404 Hum Genet (2008) 124:399–4100.4%), with frequencies signiWcantly diVerent between
the two groups [P < 0.001; odds ratio (OR) = 7.9; 95% con-
Wdence interval (CI) 1.8–33.8]. When only pure idiopathic
patients were considered (n = 284), the frequency was
raised to 3.9% and the OR to 9.4 (95% CI 2.1–42.2). In
contrast, the frequency of b2/b3 deletion was not diVer-
ent between patients and controls (3/556, 0.5% vs. 1/487,
0.2%; n.s.).
DAZ and CDY1 gene copy deWnition
To further characterize the deletions and to distinguish
between “false” deletions and deletion–duplication, we deW-
ned the type of missing DAZ (DAZ1/DAZ2 or DAZ3/DAZ4)
and CDY1 (CDY1a/CDY1b) gene copies. In patient A624,
by using gene dosage analysis, we found four DAZ copies
and two CDY1 copies, which was compatible either with a
“false” deletion or with a “gr/gr deletion–b2/b4 duplication”
event. With the RFLP analysis, we were able to identify
only one type of CDY1 (CDY1a) and DAZ pair (DAZ3/4),
which clearly suggested that gr/gr deletion has occurred
and that was followed by a b2/b4 duplication. In case of
false deletion, we would have found two diVerent DAZ
duplets and two types of CDY1 copies.
On the basis of the RFLP analysis, we distinguished four
diVerent deletion “subtypes”: deletion of DAZ1/DAZ2 +
CDY1a (subtype 1), DAZ3/DAZ4 + CDY1a (subtype 2),
DAZ1/DAZ2 + CDY1b (subtype 3), DAZ3/DAZ4 + CDY1b
(subtype 4). The additional SFV assays for each DAZ copy
have been performed in 23 of 24 cases of partial AZFc dele-
tions (Table 2). In 18 cases, results were in concordance
with the sY587 assay, i.e., showing the removal of either
the DAZ1/DAZ2 or the DAZ3/DAZ4 duplets. In four cases
in which the removal of DAZ3/DAZ4 was predicted accord-
ing to sY587, Y-DAZ3 (speciWc for DAZ3) and DAZ-SNV I
(speciWc for DAZ4) analysis, the DAZ-SNV III showed the
absence of the DAZ2 copy as well. Given that the gene dos-
age indicated the presence of two DAZ copies and the
DAZ1-speciWc SNV resulted also positive, we considered
these patients as DAZ3/DAZ4 deleted. In patient A624, the
single DAZ copy SNV analysis showed the presence of
three diVerent DAZ copies (DAZ1, DAZ3 and DAZ4),
whereas the gene dosage detected the presence of four DAZ
copies. We considered this patient as DAZ1/DAZ2 deleted
on the basis of the combined sY587 and DAZ-SNV III
(showing the absence of DAZ2) results. In conclusion, dis-
crepant results were detected regarding gene copy loss
when multiple SFVs were compared in 27% (4/15) of
DAZ3/DAZ4 deletions and 13% (1/8) in DAZ1/DAZ2 dele-
tions. These Wgures are concordant with other studies in
which these eVects have previously been reported as a
consequence of gene conversion (Repping et al. 2003; Lin
et al. 2007; Navarro-Costa et al. 2007; StouVs et al. 2008).
The observed discordances between gene dosage and SFV
analysis may be related to the variability in DAZ sequences
among individuals (polymorphisms) or gene conversion in
the DAZ-SNVs.
Given the position of the CDY1b copy in the reference
sequence, deletions involving CDY1b can be explained
either by invoking an inversion polymorphism of the P1 pal-
indrome or by gene conversion of CDY1a to CDY1b prior to
deletion. Concerning the latter hypothesis, Machev et al.
(2004) report a predicted frequency of this speciWc gene
conversion event of <1%, whereas a relatively high conver-
sion rates for the same region were previously detected in
human and primates (Rozen et al. 2003). The high percent-
age of subjects with CDY1b deletion (30%) in our study and
in that of Machev et al. (2004) suggests a more likely
involvement of an inversion polymorphism of the P1 palin-
drome rather than a gene conversion event. Nevertheless,
much care must be taken when single RFLP analysis is per-
formed for the prediction of partial AZFc deletions, since the
Machev et al. paper has also reported that CDY1 SFV-based
deletion analysis may lead to high false deletion rate. Our
data therefore indicate the importance of a combined gene
dosage and multiple RFLP analysis to improve the reliability
of the proposed deletion mechanisms.
In our 20 subjects bearing a gr/gr deletion, we found all
deletion subtypes, although at diVerent frequencies: subtype
1 (5/20; 25%), subtype 2 (9/20; 45%), subtype 3 (3/20; 15%),
subtype 4 (3/20; 15%). Accordingly, CDY1a was missing in
70% of cases. The four subjects with b2/b3 deletion belong
to subtypes 2 (1/4, 25%) and 4 (3/4, 75%) and, thus, in all b2/
b3 deletions, the DAZ3/4 gene pair was missing.
Genotype–phenotype correlation
gr/gr and b2/b3 deletions were associated with a wide range
of sperm counts, from oligozoospermia to normozoosper-
mia. We found no azoospermic men with partial AZFc
deletions. The phenotype of gr/gr deletion carriers is
reported in Table 3. The only subject with gr/gr deletion–
b2/b4 duplication (A624) was moderate oligozoospermic
(sperm concentration: 9.4 million spermatozoa/ml; progres-
sive motility: 15%; normal morphology 19%). In our study
population, CDY1a deletion was a speciWc feature of the
patient group and the diVerence between the frequencies of
gr/gr deletions with missing CDY1a in patients (14/18,
78%) and controls (0/2, 0%) was signiWcant (P = 0.026).
Interestingly, the majority of the patients belonged to sub-
types 1 and 2 (CDY1a and DAZ1/2 or DAZ3/4 deleted),
whereas both normozoospermic controls with gr/gr deletion
belonged to subtype 4, in which DAZ3/4 and CDY1b were
deleted.
The Y chromosome haplogroup in patients and controls
bearing partial AZFc deletions are reported in Table 3, for123
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controls precludes any speculation about the eVect of Y
background on the phenotypic expression of partial AZFc
deletions.
Sperm phenotype
To verify whether the presence of gr/gr deletion inXuences
sperm parameters in cases and controls, we compared the
means of the three principal sperm parameters among the
two groups. The means of the three principal sperm param-
eters were not signiWcantly diVerent between subjects with
and without gr/gr deletions, neither among patients nor
among controls (Table 4).
Since a gr/gr deletion with missing CDY1a was observed
only in patients, it seems to be more deleterious for sper-
matogenesis. Nevertheless, the means of the three principal
sperm parameters were not signiWcantly diVerent between
patients with CDY1a and CDY1b deletions (Table 4).
Partial AZFc duplications
Frequency of partial AZFc duplications in patients 
and normozoospermic men
Based on the DAZ and CDY1 gene dosage, it was possible
to identify partial duplications of AZFc region, which is
characterized by a higher number of both DAZ and CDY1
gene copies than the reference AZFc sequence (>4 and >2
for DAZ and CDY1, respectively). In all “duplication”
cases, we found three copies of CDY1 and six copies of
DAZ, indicating a partial duplication of the region containing
Table 2 Summary of DAZ SFV analysis
The sY587 analysis allows the detection of presence/absence of DAZ duplets: DAZ1/DAZ2 and DAZ3/DAZ4. For each DAZ copy, a speciWc SFV
was further analyzed
“+” presence of the corresponding DAZ copy; “¡” absence of the corresponding DAZ copy; n.d. not determined
a Samples with discordant results
Code Deleted DAZ copies (sY587) DAZ1 (DAZ-SNV II) DAZ2 (DAZ-SNV III) DAZ3 (Y-DAZ3) DAZ4 (DAZ-SNV I)
Infertile men with gr/gr deletion
A170a 3/4 + ¡ ¡ ¡
A186 1/2 ¡ ¡ + +
A202 1/2 ¡ ¡ + +
A234 3/4 + + ¡ ¡
A239 1/2 ¡ ¡ + +
A286a 3/4 + ¡ ¡ ¡
A322 3/4 + + ¡ ¡
A500 3/4 + + ¡ ¡
A522 1/2 ¡ ¡ + +
A624a 1/2 + ¡ + +
MMP55 1/2 ¡ ¡ + +
MMP93 1/2 ¡ ¡ + +
MMP109 3/4 + + ¡ ¡
MMP179 3/4 + + ¡ ¡
MMP259 3/4 n.d. n.d. n.d. n.d.
MMP289 3/4 + + ¡ ¡
MMP345a 3/4 + ¡ ¡ ¡
MMP551 1/2 ¡ ¡ + +
Normozoospermic men with gr/gr deletion
CS111 3/4 + + ¡ ¡
CSS47 3/4 + + ¡ ¡
Infertile men with b2/b3 deletion
A49 3/4 + + ¡ ¡
A353a 3/4 + ¡ ¡ ¡
A590 3/4 + + ¡ ¡
Normozoospermic men with b2/b3 deletion
CS64 3/4 + + ¡ ¡123
406 Hum Genet (2008) 124:399–410Table 3 Phenotype of patients and controls bearing gr/gr deletions, b2/b3 deletions and partial AZFc duplication with the indication of gene copy
deletion pattern deWned on the basis of the type of CDY1 and DAZ copy loss and Y hgr
Code Phenotype Y hgr Deleted gene 
copies
Sperm parameters
DAZ CDY1 Concentration 
(no. of sp/ml £ 106)
Motility 
A + B (%)
Normal 
morphology (%)
Infertile men with gr/gr deletion
A170 Idiopathic J 3/4 a 0.9 20 16
A186 Varicocelea J 1/2 a 0.6 0 2
A202 Idiopathic R1b1c 1/2 a 10 30 13
A234 Varicocelea E 3/4 a 0.7 3 8
A239 Idiopathic R1b1c 1/2 a 4.2 14 16
A286 Idiopathic I 3/4 b 0.01 – –
A322 Idiopathic G 3/4 a 1 10 15
A500 Idiopathic Fb (£G, H, I, J) 3/4 a 2.2 10 3
A522 Prostatitis R1b1c 1/2 b 4.3 20 21
A624b Varicocelea G 1/2 b 9.4 15 19
MMP55 Idiopathic R1b1c 1/2 a 9.0 6 25
MMP93 Varicocelea J 1/2 b 6.0 7 26
MMP109 Varicocelea K2 3/4 a 7.0 9 23
MMP179 Idiopathic K2 3/4 a 2.0 – –
MMP259 Idiopathic n.d. 3/4 a 7.0 6 20
MMP289 Idiopathic R1b1c 3/4 a 3.0 – –
MMP345 Varicocelea J 3/4 a 12.0 3 27
MMP551 Idiopathic J 1/2 a 11.0 4 21
Normozoospermic men with gr/gr deletion
CS111 DE 3/4 b 153.0 63 30
CSS47 E 3/4 b 60.0 47 32
Infertile men with b2/b3 deletion
A49 Idiopathic E 3/4 b 0,4 10 13
A353 Idiopathic F 3/4 a 10.0 15 22
A590 Varicocelea E 3/4 b 3.9 46 8
Normozoospermic men with b2/b3 deletion
CS64 N3 3/4 b 100.0 78 40
Infertile patients with partial AZFc duplication
A395 Idiopathic Yb (£A, D, E, J, K) 4.4 8 9
A413 Idiopathic Yb (£A, D, E, J, K) 0.01 – –
A429 Idiopathic DE 0.0 0 0
A535 Varicocelea Kb (£N3, P) 0.5 1 16
A647 Prostatitis P 2.5 19 12
MMP493 Idiopathic P 10.0 7 19
Normozoospermic controls with partial AZFc duplication
C74 F 110.0 55 31
C90 J 110.0 69 41
CS26 F 100.0 51 34
CS68 F 41.0 69 39
CS76 F 55.0 76 37
CS88 P 150.0 67 34
CS161 J 60.0 57 44123
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our study population was 16 of 492 (3.2%). Their frequency
in patients (6/229; 2.6%) versus controls (10/263; 3.8%)
was not signiWcantly diVerent (P = 0.461) even when the
comparison was restricted to the group of “idiopathic”
infertile patients (4/120; 3.3%) versus controls.
Genotype–phenotype correlation
Partial AZFc duplications were associated with a wide
range of sperm count, from azoospermia to normozoosper-
mia (Table 1). The means were not signiWcantly diVerent
between subject with and without partial AZFc duplication,
neither among patients nor among controls (Table 3).
Discussion
This study reinforces our previous Wnding and provides
strong evidence that gr/gr deletion is a risk factor for
impaired sperm production in a Caucasian population such
as the Italian. It is the largest study population in the litera-
ture in which patients and controls were ethnically and geo-
graphically strictly matched (excluding recruitment bias)
and in which the gene dosage combined to RFLP analysis
conWrmed in all cases the loss of genetic material (deletion)
or the presence of a deletion followed by b2/b4 duplication
(excluding false deletions). This data are in agreement
with the recent meta-analysis (Tuttelmann et al. 2007),
which, despite the multitude of biases of published studies,
Table 3 continued
n.d. not determined
a In all cases, varicocele was unilateral and grade < 2
b gr/gr deletion–b2/b4 duplication
Code Phenotype Y hgr Deleted gene 
copies
Sperm parameters
DAZ CDY1 Concentration 
(no. of sp/ml £ 106)
Motility 
A + B (%)
Normal 
morphology (%)
MM85 Yb (£A, D, E, J, K) 38.0 51 50
MM103 Yb (£A, D, E, J, K) 69.0 50 43
MM110 Yb (£A, D, E, J, K) 37.0 50 37
Table 4 Means § SD of the three principal semen parameters (A) in patients with gr/gr and b2/b3 deletion and without partial AZFc deletions,
and in controls with and without gr/gr deletion, and (B) in patients and controls with and without partial AZFc duplication
a The mean values of three principal semen parameters in gr/gr deletion carriers with CDY1a and CDY1b copy loss are separately shown
b Means for b2/b3 deletions are not reported for controls, since only one carrier was found in this group
c No signiWcant diVerences were found for any of the three sperm parameters between carriers of partial deletion or duplications and noncarriers
Sperm concentration 
(no. of sp/ml £ 106)
Motility 
A + B (%)
Morphology (%)
A Patients
With gr/gr deletion (n = 18) 5.0 § 4.0 9.9 § 8.1 16.7 § 7.9
With b2/b3 deletion (n = 3) 4.8 § 4.9 23.5 § 19.2 14.3 § 7.1
Without partial AZFc deletions (n = 535) 5.4 § 5.4 10.4 § 11.6 17.5 § 7.2
Patients with gr/gr deletiona
CDY1a copy loss (n = 14) 5.0 § 4.2 8.8 § 8.4 15.4. § 8.2
CDY1b copy loss (n = 4) 4.9 § 3.9 14 § 6.5 22 § 3.6
Controlsb
With gr/gr deletion (n = 2) 106.5 § 65.8 55.0 § 11.3 31.0 § 1.4
Without gr/gr deletion (n = 485) 91.2 § 63.8 58.2 § 10.8 38.7 § 8.6
B Patientsc
With partial AZFc duplication (n = 6) 2.9 § 3.9 11.3 § 6.7 14.0 § 4.4
Without partial AZFc duplication (n = 223) 5.5 § 6.9 13.6 § 13.6 15.4 § 6.4
Controlsc
With partial AZFc duplication (n = 10) 77.0 § 38.4 59.5 § 9.8 39.0 § 5.7
Without partial AZFc duplication (n = 253) 90.4 § 57.9 59.8 § 9.7 38.6 § 7.7123
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(P < 0.001). In our Central Italian study population, gr/gr
deletion carriers have a 7.9-fold increased risk of having
impaired spermatogenesis compared with men without
such a deletion. According to Repping et al. (2003), if gr/gr
deletions were selectively neutral, then population genetic
theory suggests that more than 40% would be gr/gr-deleted.
The combined frequency of gr/gr deletions in our study
population is 1.9%. While the prevalence of the complete
AZFc deletion—which speciWcally causes spermatogenic
failure—is less than 0.03% (i.e. approximately the rate at
which new deletions arise), the relatively high prevalence
of gr/gr deletions reXect a combination of low penetrance
and high mutability (the target of homologous recombina-
tion is three times the size of the target of the complete
AZFc deletion) (Repping et al. 2003). In our study popula-
tion, all gr/gr deletion carriers had spermatozoa in their
ejaculates and 9 of 20 were moderate/mild oligozoosper-
mic. This Wnding further supports the hypothesis that gr/gr
deletions do not induce a drastic phenotypic eVect. We
attempted to deWne whether the molecular characterization
of gr/gr deletions may lead to the distinction between
“pathogenic” and “neutral” deletions. Although we found
that our two normozoospermic controls clustered in sub-
type 4 (DAZ3/4- and CDY1b-deleted), which was shared
only by 1 of 18 patients, and CDY1a deletion was a speciWc
feature of the patient group, conclusions about the subtypes
cannot be drawn due to the low number of deletion carriers.
However, a similar prevalence of gr/gr deletions removing
the DAZ1/DAZ2 copies was reported in infertile men of
Caucasian origin by other groups (Fernandes et al. 2002;
Ferlin et al. 2005). Interestingly, a similar observation was
made also in the Chinese Han population in which only the
sY1291/DAZ1/DAZ2 deletion (and not the sY1291/DAZ3/
DAZ4 deletion) is a signiWcant risk factor for spermato-
genic impairment (Yang et al. 2008). Recently, Navarro-
Costa et al. (2007) have also attempted to further character-
ize partial AZFc deletion subtypes with amplicon-speciWc
sequence markers. They found highly heterogeneous AZFc
deletion products in terms of amplicon content; however,
no speciWc subtype was identiWed for infertile or fertile
men. It is worth to note that the sperm count of fertile
controls were unknown; therefore, the conclusion of Costa
et al. (2007) remains limited to the “fertility” status.
Our study is in contrast with a number of others
(Table 1). Among the most plausible explanations are the
following: (1) methodological diVerences (lack of conWr-
mation of deletions by gene dosage); (2) inappropriate
selection of controls (unknown sperm count); (3) lack of
ethnic and/or geographic matching of the patients versus
controls. This latter bias is especially relevant in popula-
tions with a high proportion of subjects with constitutive gr/gr
deletions, in which the deletion may be compensated by
other Y-related factors. Consequently, case–control studies
from these countries and those based on admixed popula-
tions (de Llanos et al. 2005; Ravel et al. 2006; StouVs et al.
2008) are especially susceptible to recruitment bias.
DiVerent clinical inclusion criteria applied for the selec-
tion of patients and controls are also an important issue.
The highest deletion frequency was found among oligozoo-
spermic men and considering only this group of patients the
OR in our study rises to 9.1 (P < 0.001; 95% CI 2.1–38.8).
On the contrary, it is highly likely that idiopathic azoosper-
mia is not caused by a risk factor but is rather related to
causative mutation(s) in essential spermatogenic genes.
Studies including a high proportion of azoospermic in
respect to oligozoospermic men may therefore miss those
subjects, which are the more likely carriers of gr/gr dele-
tions. Apart from the heterogeneous semen phenotypes,
patient exclusion criteria are also extremely diVerent
among diVerent studies. It is clearly shown in Supplemen-
tary Table 1 that only a few studies provided evidence
about the exclusion of all known causes of impaired sper-
matogenesis in their patient group. Therefore, the associa-
tion between gr/gr deletion and spermatogenic failure may
be weakened or lost by a relatively high proportion of
patients with known causes of spermatogenic failure. This
potential selection bias may not be crucial when patients
with Wrst grade varicocele or a history of previous (but not
recurrent) infection are included, because these pathologi-
cal conditions are not proven causes of impaired spermato-
genesis and can be found frequently also in normospermic
men. In fact, although our study population contained also
patients with the aforementioned mild abnormal andrologi-
cal Wndings, we still observed a signiWcantly higher gr/gr
deletion frequency in the whole patient group in respect to
controls. Moreover, the frequency between the two patient
subgroups were similar (3.9% in the “idiopathic” and 2.6%
in the “cofactor” group) and signiWcantly diVerent in
respect to the control group, with a P value < 0.001 in the
“idiopathic” (OR 9.4; 95% CI 2.1–42.2) and P < 0.01 in
the “cofactor” group (OR 6.3; 95% CI 1.3–29.9). Also the
composition of the normoozoospermic group may inXuence
the outcome of a case–control study, since even in popula-
tions in which gr/gr deletion is relatively frequent in nor-
mozoospermic men (Asian), the deletion frequency
drastically decreases in subgroups with sperm counts >50
millions spermatozoa/ml (Yang et al. 2006).
In our study, we avoided all potential methodological
and selection biases thereby providing highly reliable data
about a signiWcant association between gr/gr deletion and
spermatogenic failure (OR = 7.9). Although we already
found a signiWcant association in our previous study on 339
subjects, obviously the clinical meaning of the same Wnding
in >1,000 subjects is drastically diVerent and represents a
unique example in the Weld (Table 5). In fact, the lack of123
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common phenomenon, and in general the Wrst study tends
to overestimate the disease protection or predisposition
conferred by a genetic polymorphism (Ioannidis et al.
2001; Krausz and Giachini 2007). Our Wnding implies that
gr/gr deletion screening, by identifying a cofactor for
impaired sperm production, may have diagnostic value.
Moreover, since this genetic risk factor will be obligatorily
transmitted to the male oVspring, it is also relevant for
genetic counselling, i.e., to inform the couple about the
transmission of a predisposition to impaired sperm
production.
Concerning partial AZFc duplications, we were unable
to detect a signiWcant eVect of an excess AZFc gene dosage
on spermatogenesis. Ours is the Wrst study in a Caucasian
population and the discordance with the only study report-
ing such an association, based on a Han-Chinese population
(Lin et al. 2007), may reXect genuine ethnic diVerences or
related to diVerent sample sizes.
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